Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Cervical Cancer

Free Subscription 10.11.2025 1 Adv Healthc Mater 1 Afr Health Sci 2 Am J Obstet Gynecol 2 Ann Med Surg (Lond) 1 BMC Cancer 1 BMC Med Inform Decis Mak 1 BMC Public Health 1 BMJ Public Health 2 Cancer Control 2 Cancer Epidemiol Biomarkers Prev 1 Cancer Rep (Hoboken) 1 Cell Mol Life Sci 1 Ceska Gynekol 1 Chin Med J (Engl) 1 Chirurgia (Bucur) 1 Cureus 1 Curr Med Sci 1 Discov Oncol 1 Eur J Nucl Med Mol Imaging 3 Front Oncol 1 Front Public Health 1 Gynecol Oncol 2 Int J Cancer 1 Int J Gynaecol Obstet 5 Int J Gynecol Cancer 1 Int J Infect Dis 2 Int J Womens Health 1 J Appl Clin Med Phys 1 J Appl Lab Med 1 J Clin Ultrasound 1 J Dermatol 1 J Med Virol 1 J Nat Med 1 J Natl Cancer Inst 1 J Obstet Gynaecol Res 1 J Transl Med 1 Mol Cell Biochem 1 Mol Pharm 1 Obstet Gynecol Surv 1 Pathology 1 Sex Transm Dis 1 Trials 1 Tzu Chi Med J 1 Zhonghua Bing Li Xue Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Adv Healthc Mater

1. LI J, Zheng C, Zhang L, Hong C, et al
   In Situ Formed Nanocomposite Hydrogel Improve Local Delivery of Antiangiogenic Agents and Immune Checkpoint Inhibitor for Cervical Carcinoma Therapy.
   Adv Healthc Mater. 2025;14:e2502085.
   PubMed         Abstract available
   
   

   
   Afr Health Sci

2. AKONDE M, Anyinka J, Abah GA, Gupta RD, et al
   Factors associated with clinical breast examination and cervical cancer screening uptake in Ghanaian women, Evidence from the 2022 Ghana Demographic and Health Survey.
   Afr Health Sci. 2025;25:123-135.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

3. LI Q
   Long-term lymphedema and quality of life following lymph node staging in early cervical cancer (Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Nov 2:S0002-9378(25)00818.
   PubMed        
   
   
4. OSTENFELD EB, Bjornholt SM, Jensen PT
   Lymph node removal and long-term lymphedema in cervical cancer. (Reply to Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Nov 2:S0002-9378(25)00819.
   PubMed        
   
   

   
   Ann Med Surg (Lond)

5. OBEAGU EI
   From inflammation to invasion: neutrophils in cervical cancer pathogenesis.
   Ann Med Surg (Lond). 2025;87:7112-7127.
   PubMed         Abstract available
   
   
6. OBEAGU EI
   Integrating neutrophil-to-lymphocyte ratio into cervical cancer management: implications for prognostic assessment and therapeutic strategies - a narrative review.
   Ann Med Surg (Lond). 2025;87:7362-7368.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. ZHOU Y, Guo X, Han J, Ding W, et al
   DDR1 drives cervical cancer progression and immune evasion: a bioinformatics analysis with experimental verification.
   BMC Cancer. 2025;25:1716.
   PubMed         Abstract available
   
   

   
   BMC Med Inform Decis Mak

8. AL-HEJRI AM, Al-Tam RM, Sable AH, Almuhaya B, et al
   A hybrid vision transformer with ensemble CNN framework for cervical cancer diagnosis.
   BMC Med Inform Decis Mak. 2025;25:411.
   PubMed         Abstract available
   
   

   
   BMC Public Health

9. ABU-ELENIN MM, Shahin MA, Abdeldaim DE
   Preventive insights and practices of female health professionals regarding cervical cell dysplasia: a cross-sectional study in Egypt.
   BMC Public Health. 2025;25:3809.
   PubMed         Abstract available
   
   

   
   BMJ Public Health

10. SILAS GD, Uggh IHP, Njau B, Majaliwa E, et al
    Female sex workers and cervical cancer screening in Kilimanjaro region: Uptake and Behavioural Determinants in Health Belief Model Perspectives: A community-based cross-sectional study.
    BMJ Public Health. 2025;3:e002543.
    PubMed         Abstract available
    
    

    
    Cancer Control

11. DOLORES E, Kaire I, Reeli H, Piret V, et al
    Prevalence of Human Papillomavirus Subtypes and Related Cytology in Estonian Cervical Cancer Screening Population in 2021.
    Cancer Control. 2025;32:10732748251376787.
    PubMed         Abstract available
    
    
12. BISKUP E, Andreou I, Poulsen TS, Lopacinska-Jorgensen J, et al
    Comparative Performance of Methylation Array and Bisulfite Sequencing in Ovarian Tissue Samples and Cervical Swabs.
    Cancer Control. 2025;32:10732748251386499.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

13. SHAH V, Shah D, DeStefano V, Bonetti M, et al
    Occupational-Related Exposure to Benzene and Risk of Cervical, Ovarian, and Endometrial Cancers: Systematic Review and Meta-analysis.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1877-1887.
    PubMed         Abstract available
    
    
14. MOUCHERAUD C, Ochieng E, Golub G, Navario P, et al
    Kenyan men and cervical cancer prevention: Insights from a national survey.
    Cancer Epidemiol Biomarkers Prev. 2025 Nov 7. doi: 10.1158/1055-9965.EPI-25-0987
    PubMed         Abstract available
    
    

    
    Cancer Rep (Hoboken)

15. MA J, Ma F, Chen T, Lu X, et al
    Precision Diagnosis and Individualized Therapy of Non-Gestational Choriocarcinoma Invading the Corpus Uteri and Cervix: A Case Report and Literature Review.
    Cancer Rep (Hoboken). 2025;8:e70393.
    PubMed         Abstract available
    
    

    
    Cell Mol Life Sci

16. LU L, Wang F, Wang T, Xing Z, et al
    Hypoxia drives cervical cancer progression via OCT4/ORAI3-dependent glycolysis and Ca(2+) signaling.
    Cell Mol Life Sci. 2025;82:390.
    PubMed         Abstract available
    
    

    
    Ceska Gynekol

17. MANTOANI PTS, Melo GA, Vieira JH, Correa Magalhaes T, et al
    Hematological parameters and colposcopic lesion area in precursor lesions of cervical cancer.
    Ceska Gynekol. 2025;90:309-314.
    PubMed         Abstract available
    
    

    
    Chin Med J (Engl)

18. CHEN L, Chen W, Lin Y, Li X, et al
    Serum immune parameters as predictors for treatment outcomes in cervical cancer treated with concurrent chemo-radiotherapy.
    Chin Med J (Engl). 2025 Nov 7. doi: 10.1097/CM9.0000000000003553.
    PubMed         Abstract available
    
    

    
    Chirurgia (Bucur)

19. KANTZOU I, Georgakopoulos I, Markou I, Vorgias G, et al
    Three Dimensional Conformal versus Volumetric Arc Therapy in Gynecological Cancer: A Retrospective Study Evaluating Therapeutic Effect and Toxicity.
    Chirurgia (Bucur). 2025;120:538-545.
    PubMed         Abstract available
    
    

    
    Cureus

20. KULKARNI P, Khare S, Bramhachari S, Das S, et al
    Collagen-Embedded Three-Dimensional Spheroid Model Based on Breast and Cervical Cancer for Drug Screening Application.
    Cureus. 2025;17:e93920.
    PubMed         Abstract available
    
    

    
    Curr Med Sci

21. DENG JX, Zhang LY, Ouyang ZQ, Guo T, et al
    TM4SF1 as a Prognostic Biomarker and Therapeutic Target in Cervical Cancer.
    Curr Med Sci. 2025 Nov 3. doi: 10.1007/s11596-025-00123.
    PubMed         Abstract available
    
    

    
    Discov Oncol

22. MO D, Cao H, Lai S, Luo J, et al
    Spatial transcriptomic landscape and cellular neighborhood heterogeneity in cervical cancer: integrative single-cell and spatial RNA sequencing analysis.
    Discov Oncol. 2025;16:2040.
    PubMed         Abstract available
    
    

    
    Eur J Nucl Med Mol Imaging

23. KING BG, Bharwani N, Wilson W, Cook GJR, et al
    Diagnostic performance of quantitative measures from [(18)F]FDG PET/CT, [(18)F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING study.
    Eur J Nucl Med Mol Imaging. 2025 Nov 3. doi: 10.1007/s00259-025-07587.
    PubMed         Abstract available
    
    

    
    Front Oncol

24. XIAO N, Yuan C, Zhao T, Xu T, et al
    Comparative impact of supine vs prone positioning on dose distribution, acute toxicity, and setup error in postoperative radiotherapy for cervical cancer: a multidimensional propensity-matched cohort study.
    Front Oncol. 2025;15:1637443.
    PubMed         Abstract available
    
    
25. TRUJANO-CAMACHO S, Contreras-Romero C, Garcia-Castillo V, Sanchez-Marin D, et al
    Long noncoding RNAs involved in therapeutic response: implications for cervical cancer drug resistance.
    Front Oncol. 2025;15:1644104.
    PubMed         Abstract available
    
    
26. ZHANG Z, Luo X, Zhao H
    Commentary: A quantitative analysis of artificial intelligence research in cervical cancer: a bibliometric approach utilizing CiteSpace and VOSviewer.
    Front Oncol. 2025;15:1666369.
    PubMed        
    
    

    
    Front Public Health

27. LIU W, Jing L, Huang X, Huang H, et al
    Cost-effectiveness of cervical cancer screening and HPV vaccination: a Markov model from the healthcare payer perspective.
    Front Public Health. 2025;13:1508623.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

28. ETTORRE VM, Demirkiran C, Bellone S, Hartwich TMP, et al
    Effective preclinical activity of datopotamab deruxtecan (Dato-DXd), an ADC targeting trophoblast cell-surface antigen 2 (TROP2), against primary cervical carcinoma cell lines and xenografts.
    Gynecol Oncol. 2025;201:195-202.
    PubMed         Abstract available
    
    

    
    Int J Cancer

29. ANDERSEN K, Bonde J, Waldstrom M, Jakobsen MV, et al
    Evaluation of targeted next-generation sequencing for detection of HPV genotypes and sublineages in cervical liquid-based cytology SurePath samples from the Danish screening program.
    Int J Cancer. 2025 Sep 11. doi: 10.1002/ijc.70148.
    PubMed         Abstract available
    
    
30. SA P, Monteiro P, Henrique R, Lunet N, et al
    The cervical cancer screening program in the North of Portugal: Outcomes after nearly two decades of coexistence with the human papillomavirus vaccine.
    Int J Cancer. 2025 Nov 3. doi: 10.1002/ijc.70196.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

31. FUJITA H, Okamoto K, Kato H, Watari H, et al
    Combination of transvaginal ultrasound with cervical cancer screening contributes to early detection of ovarian cancer: Clinical trial.
    Int J Gynaecol Obstet. 2025 Nov 3. doi: 10.1002/ijgo.70599.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

32. SHANG X, Qiu L, Liu Y, Chen H, et al
    Role of the novel optoelectronic imaging tracing system in cervical cancer screening: preliminary outcomes of a multi-center study.
    Int J Gynecol Cancer. 2025;35:102716.
    PubMed         Abstract available
    
    
33. BAIOCCHI G, Zanvettor PH, Lopes A, Ribeiro R, et al
    Reconsidering adjuvant radiotherapy in intermediate-risk cervical cancer: findings from the CIRCOL study group.
    Int J Gynecol Cancer. 2025;35:102723.
    PubMed         Abstract available
    
    
34. WRIGHT JD, Bizzarri N, Agarwal J, Chen L, et al
    Association of sentinel lymph node biopsy and isolated tumor cells in cervical cancer.
    Int J Gynecol Cancer. 2025 Oct 11:102721. doi: 10.1016/j.ijgc.2025.102721.
    PubMed         Abstract available
    
    
35. O'HARA CA, Khoo ZKH, Dimech C, Chong NZ, et al
    Screening of human papilloma virus-related anogenital cancers in immunocompromised women: a systematic review of clinical practice guidelines.
    Int J Gynecol Cancer. 2025;35:102131.
    PubMed         Abstract available
    
    
36. FARZANEH F, Dastyar F, Mohammadi M, Hosseini MS, et al
    Long-term oral contraceptive use as a risk factor for high-grade cervical lesions in women with high-risk human papillomavirus: a retrospective cohort analysis.
    Int J Gynecol Cancer. 2025;35:102650.
    PubMed         Abstract available
    
    

    
    Int J Infect Dis

37. DU H, Dai W, Wu D, Liu Y, et al
    Expanding access to cervical cancer screening: the performance of self-sampled urine HPV testing.
    Int J Infect Dis. 2025 Oct 30:108175. doi: 10.1016/j.ijid.2025.108175.
    PubMed         Abstract available
    
    

    
    Int J Womens Health

38. WU Y, Wang A
    A Review on the Applications of Artificial Intelligence for Diagnosing and Treating Cervical Cancer.
    Int J Womens Health. 2025;17:3955-3970.
    PubMed         Abstract available
    
    
39. XU J, Wang M, Jia Y, Chen Y, et al
    Study on Differential Metabolites Between Human Papillomavirus Infection and Cervical Cancer Based on Non-Targeted Metabolomics.
    Int J Womens Health. 2025;17:3995-4009.
    PubMed         Abstract available
    
    

    
    J Appl Clin Med Phys

40. YOO D, Kim H, Park S, Choi H, et al
    Validating clinical feasibility of MRCAT and deep learning-based synthetic CT images for cervical cancer patient.
    J Appl Clin Med Phys. 2025;26:e70332.
    PubMed         Abstract available
    
    

    
    J Appl Lab Med

41. LOVING HS
    Practical Considerations for Cervical Cancer Screening.
    J Appl Lab Med. 2025;10:1771-1772.
    PubMed        
    
    

    
    J Clin Ultrasound

42. MACHADO P, Vu T, Rosenblum N, Shafer A, et al
    Initial Evaluation of Lymphosonography to Identify Sentinel Lymph Nodes in Cervical and Vulvar Cancer Patients.
    J Clin Ultrasound. 2025;53:2159-2164.
    PubMed         Abstract available
    
    

    
    J Dermatol

43. SHIMADA Y, Ono H, Takeda K, Shimizu A, et al
    Myiasis in a Skull Metastatic Nest of Cervical Cancer.
    J Dermatol. 2025;52:1718-1721.
    PubMed         Abstract available
    
    

    
    J Med Virol

44. CHUNG PYJ, Baraquin A, Jacquot K, Tkachenka Y, et al
    Reproducibility of HPV Testing With Two Versions of the Papilloplex High-Risk HPV Assay.
    J Med Virol. 2025;97:e70680.
    PubMed         Abstract available
    
    

    
    J Nat Med

45. LI C, Luo P, Tang L, Yang Y, et al
    Digoxin targets BHLHE40 to inhibit epithelial-mesenchymal transition in cervical cancer cells via downregulation of ANGPTL3.
    J Nat Med. 2025 Nov 5. doi: 10.1007/s11418-025-01947.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

46. CASTLE PE, Befano B, Hyer M, Cheung LC, et al
    Impact of repeatedly screening negative on cervical cancer risk.
    J Natl Cancer Inst. 2025 Nov 3:djaf317. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol Res

47. AKBARI F, Vejdani R, Yaghoubi-Kondelaji S, Zarghami F, et al
    Fertility Preservation in Extramedullary Plasmacytoma of the Uterine Cervix: Global Literature Synthesis and First Case From Iran.
    J Obstet Gynaecol Res. 2025;51:e70130.
    PubMed         Abstract available
    
    

    
    J Transl Med

48. TIAN X, Lin R, Bao J, Pan Y, et al
    Integrated single-cell, spatial, and bulk transcriptomics reveal a chromatin regulator-TME prognostic framework guiding precision therapy in cervical cancer.
    J Transl Med. 2025;23:1235.
    PubMed         Abstract available
    
    

    
    Mol Cell Biochem

49. PU C, Xing B, Wang S, Liu Z, et al
    Advancements in single-cell sequencing for cervical cancer research.
    Mol Cell Biochem. 2025 Nov 6. doi: 10.1007/s11010-025-05407.
    PubMed         Abstract available
    
    

    
    Mol Pharm

50. ZHU H, Zhang Z, Ye J, Yang H, et al
    Evaluation of the Antitumor Efficacy of Human Papillomavirus Type 16 E7-Affitoxin in C57BL/6JNifdc Mice Bearing TC-1 Tumors.
    Mol Pharm. 2025;22:6989-6998.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol Surv

51. DESCAMPS P, Dixon S, Bosch Jose FX, Kyrgiou M, et al
    Turning the Tide: Recommendations to Increase Cervical Cancer Screening Among Women Who Are Underscreened.
    Obstet Gynecol Surv. 2025;80:702-704.
    PubMed         Abstract available
    
    

    
    Pathology

52. BANET N, Talia KL
    Cytology and histology of endocervical glandular lesions: a review with emphasis on recent developments.
    Pathology. 2025;57:817-830.
    PubMed         Abstract available
    
    

    
    Sex Transm Dis

53. YANG L, Babalola C, Klausner JD
    A Narrative Review of Urine-Based Human Papillomavirus Screening: Performance, Challenges, and Opportunities to Expand Access in the United States.
    Sex Transm Dis. 2025;52:769-774.
    PubMed         Abstract available
    
    

    
    Trials

54. AL-OSEELY S, Abdul Manaf R, Ismail S
    Effectiveness of educational intervention on cervical cancer screening knowledge, attitude, and practice among Yemeni immigrant women in Klang Valley, Malaysia: a randomized controlled trial.
    Trials. 2025;26:466.
    PubMed         Abstract available
    
    

    
    Tzu Chi Med J

55. TSUI WL, Deng GH, Hsieh TC, Li PC, et al
    Comparison of survival between open and minimally invasive radical hysterectomies for stage IB1 cervical cancer (
    Tzu Chi Med J. 2025;37:430-436.
    PubMed         Abstract available
    
    

    
    Zhonghua Bing Li Xue Za Zhi

56. GUAN CY, Li J, Li SX, Li HL, et al
    [Application value and missed diagnosis analysis of p16/Ki-67 immunocytochemical double staining technique in cervical lesion screening].
    Zhonghua Bing Li Xue Za Zhi. 2025;54:1208-1211.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.